Clinical trial / 2012
Calcium and vitamin D3 supplementation did not reduce the risk of incident dementia or mild cognitive impairment in elderly women.
A post hoc analysis of the WHI trial evaluated 4,143 women aged 65 and older randomized to 1,000 mg of calcium carbonate plus 400 IU of vitamin D3 (n = 2,034) or placebo (n = 2,109). Over a mean follow-up of 7.8 years, incident dementia occurred in 39 treatment participants and 37 placebo participants (HR = 1.11, 95% CI = 0.71-1.74, P = .64). Incident MCI was diagnosed in 98 treatment and 108 placebo participants (HR = 0.95, 95% CI = 0.72-1.25, P = .72). There were no significant differences in incident dementia, MCI, or global and domain-specific cognitive function between groups.
- Study type
- Post hoc analysis of a randomized double-blind placebo-controlled trial
- Who was studied
- 4,143 women aged 65 and older without probable dementia at baseline (mean age 71)
- What was measured
- Probable dementia or mild cognitive impairment (MCI), global cognitive function, and individual cognitive subtests
THE PAPER
Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative.
Rossom RC, Espeland MA, Manson JE, Dysken MW, Johnson KC, Lane DS, LeBlanc ES, Lederle FA, Masaki KH, Margolis KL. J Am Geriatr Soc, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.